The role of miRNA-424 and miR-631 in various cancers: Focusing on drug resistance and sensitivity
- 16 September 2022
- journal article
- review article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 239, 154130
Abstract
No abstract availableKeywords
All Related Versions
This publication has 79 references indexed in Scilit:
- Simultaneously expressed miR-424 and miR-381 synergistically suppress the proliferation and survival of renal cancer cells—Cdc2 activity is up-regulated by targeting WEE1Clinics, 2013
- Histone Deacetylases and NF-kB Signaling Coordinate Expression of CX3CL1 in Epithelial Cells in Response to Microbial Challenge by Suppressing miR-424 and miR-503PLOS ONE, 2013
- MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistanceJournal of Ovarian Research, 2013
- Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthaseExperimental and Therapeutic Medicine, 2013
- Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast CancersPLOS ONE, 2012
- MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation statusJournal of Hematology & Oncology, 2012
- Down-Regulation of mir-424 Contributes to the Abnormal Angiogenesis via MEK1 and Cyclin E1 in Senile Hemangioma: Its Implications to TherapyPLOS ONE, 2010
- microRNA profiling in Epstein–Barr virus-associated B-cell lymphomaNucleic Acids Research, 2010
- Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulationLeukemia, 2009
- The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiationProceedings of the National Academy of Sciences, 2007